76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Treace Medical Concepts Inc
Closed
5.79 0.7
Overview
Share price change
24h
Min
5.76
Max
5.91
Income | -15M -16M |
|---|---|
Sales | -16M 53M |
EPS | -0.247 |
Profit margin | -30.287 |
Employees | 477 |
EBITDA | -15M -12M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +79.38% upside |
Next Earnings | 5 Aug 2025 |
|---|
Market Cap | -92M 361M |
|---|---|
Previous open | 5.09 |
Previous close | 5.79 |
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Treace Medical Concepts Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Treace Medical Concepts Inc Forecast
Price Target
By TipRanks
79.38% upside
12 Months Forecast
Average 10.35 USD 79.38%
High 14.5 USD
Low 8.6 USD
Based on 7 Wall Street analysts offering 12 month price targets forTreace Medical Concepts Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
